Ranbaxy Labs surged by over 7% to Rs343 after the company announced that it received approval from the U.S. Food and Drug Administration to manufacture and market Glycopyrrolate Tablets USP, 1 mg and 2 mg.
JOIN US!!
Send SMS for "STUDY" on 09825677777